Relmada Therapeutics

RLMDNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$518.158 M

$4.94 -8.01%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

$0.00

#2497 by earnings

Shares outstanding

106,669,846

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#205MapLight TherapeuticsMPLT$551.9M
#206BioAge LabsBIOA$537.9M
#207Relmada TherapeuticsRLMD$518.2M
#208EvommuneEVMN$507.1M
#209Tenax TherapeuticsTENX$503.0M

Where these numbers come from

Share counts and financials for Relmada Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.